(−)-Epigallocatechin-3-gallate mitigates cyclophosphamide-induced intestinal injury by modulating the tight junctions, inflammation and dysbiosis in mice
- 3 November 2021
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Food & Function
- Vol. 12 (22) , 11671-11685
Abstract
Schematic diagram depicting the main mechanisms of EGCG for mitigating cyclophosphamide (CTX)-induced intestinal injury.Keywords
Funding Information
- National Institute of Food and Agriculture (CA-D-NUT-2397-H)
- Zhejiang A and F University (2020FR049)
This publication has 84 references indexed in Scilit:
- Polyphenols Protect the Epithelial Barrier Function of Caco-2 Cells Exposed to Indomethacin through the Modulation of Occludin and Zonula Occludens-1 ExpressionJournal of Agricultural and Food Chemistry, 2013
- Abnormal intestinal permeability in Crohn's disease pathogenesisAnnals of the New York Academy of Sciences, 2012
- Development of a headspace solid-phase microextraction gas chromatography–mass spectrometric method for the determination of short-chain fatty acids from intestinal fermentationFood Chemistry, 2011
- Responses of Gut Microbiota and Glucose and Lipid Metabolism to Prebiotics in Genetic Obese and Diet-Induced Leptin-Resistant MiceDiabetes, 2011
- Microbial ecology of the murine gut associated with the development of dextran sodium sulfate-induced colitisInflammatory Bowel Diseases, 2011
- Cyclophosphamide and cancer: golden anniversaryNature Reviews Clinical Oncology, 2009
- Cytokines, Inflammation, and PainInternational Anesthesiology Clinics, 2007
- Epigallocatechin-3-gallate (EGCG): Chemical and biomedical perspectivesPhytochemistry, 2006
- Cyclophosphamide-induced hemorrhagic cystitis: A review of 100 patientsCancer, 1988
- Cyclophosphamide (Cytoxan)Journal of the American Academy of Dermatology, 1984